UBS Group
PLSE icon

UBS Group’s Pulse Biosciences PLSE Stock Holding History

UBS Group’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,800
Closed -$66.2K – 10603
2024
Q4 		$66.2K Sell
3,800
-10,000
-72% -$176K ﹤0.01% 7124
2024
Q3 		$242K Buy
+13,800
New +$235K ﹤0.01% 5732

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

UBS Group's PLSE Position: Q1 2026 in Review

UBS Group reduced its Pulse Biosciences (PLSE) stake by 55% in Q1 2026, selling an estimated $774K and leaving 33,954 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #5785.

UBS Group first reported a position in PLSE in Q2 2016 and has held it in 36 quarters since. The position peaked at $1.36M in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • UBS Group held 33,954 shares of Pulse Biosciences worth $733K as of Q1 2026.
  • UBS Group sold 41,955 Pulse Biosciences shares in Q1 2026, an estimated $774K.
  • Pulse Biosciences made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5785 holding.
  • UBS Group first reported a position in Pulse Biosciences in Q2 2016 and has held it in 36 quarters since.
  • UBS Group's Pulse Biosciences position peaked at $1.36M in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.